The Rundown: ExL’s Blog
Viewing 61 to 70 of 115 records.
JUST ANNOUNCED: The Innovative Regulatory Pathways Summit
Wednesday September 27th, 2017
The Innovative Regulatory Pathways Summit is taking place January 29–30, 2018 in Arlington, VA. This intimate summit will bring together leading regulatory experts and senior-level executives to discuss regulatory strategies to expedite drug development in the U.S., EU, and Japan. Download the brochure here to review the sessions and speakers featured at this event.
Breakthrough therapy designations and other expedited pathways encourage sponsors to increase communication and collaboration with the FDA. Expedited drug development options are also available globally in ICH countries…
JUST ANNOUNCED: Cannabis Partnerships Congress, March 2018 in San Francisco
Thursday September 21st, 2017
ExL Events is excited to announce the Cannabis Partnerships Congress, taking place March 12–13, 2018 in San Francisco, CA! The Cannabis Congress is an educational forum designed to bring all stakeholders involved in the cannabis-based scientific, medicinal, governmental, and product development to fortify the therapies in a collaborative environment.
Despite recent changes in state policy, and with the increasing rate of cannabis use and its implications for health, the government has yet to legalize cannabis. With the continued enforcement of restrictive policies and regulations on research into the health benefits, it is important…
Novartis, AbbVie, and GSK Discuss Expedited Drug Development Tracks
Thursday September 14th, 2017
The Innovative Regulatory Pathways Summit is taking place January 29–30, 2018 in Arlington, VA! This intimate summit will bring together leading regulatory experts and senior-level executives to discuss breakthrough therapy designations and other regulatory strategies to expedite patient drug development in the U.S., EU, and Japan. Download the brochure here to review the sessions and speakers featured at this event.
Join our professional speaking faculty, which includes representatives from:
Current Events Prove the Value-Based Reimbursement Summit Is a Can’t-Miss Event!
Friday September 8th, 2017
Since the release of the brochure for ExL’s Value-Based Strategies for Reimbursement and Formulary Success, recent news has emerged, highlighting the pressure placed on life science organizations to account for the healthcare value of drugs in reimbursement strategies. In an era of performance-driven healthcare, we have continued to follow this topic in the news. The below articles address current events in formulary access and reimbursement strategies and highlight the importance of staying up to date with industry developments.
Will the UK’s Post-Brexit Life Sciences Strategy Be a Boon for Market Access?
The highly anticipated life sciences strategy commissioned by the UK government…
Considering the Patient’s Point of View When Explaining Medication Side Effects and More
Wednesday September 6th, 2017
Starting or changing medication can be stressful for patients, especially if there is a communication barrier between them and their physician. While doctors, nurses, pharmacists and other professionals in the fields of medicine understand side effects and reactions that come with certain medications, a patient most likely does not. Taking their point of view into consideration is paramount for patient-centric care and successful treatments.
According to a recent article published by the BBC, people usually have negative responses to medical information pamphlets and the like. A new report states that patients find this form of communicating side…
Drug Donation Interactive Roundtable at the Neglected Tropical Diseases Forum!
Tuesday August 29th, 2017
ExL Events is proud to announce that Elizabeth “EJ” Ashbourne (Executive Director, PQMD) is set to speak and lead an interactive roundtable at the Neglected Tropical Diseases Forum this October 26–27 in Boston. This conference is dedicated to the multi–sector partnerships that combat NTDs and build a community of practice.
“I am participating in this forum because I am passionate about bringing together global health professionals, across the biomedical landscape, to discuss best practices for building programs to combat NTDs. This will…
The 11th Digital Pharma East Comes to the Pennsylvania Convention Center October 3–6
Wednesday August 23rd, 2017
ExL Events proudly brings the 11th Digital Pharma East conference to the Pennsylvania Convention Center in Philadelphia, PA on October 3–6, 2017. This interactive and comprehensive industry event attracts 800+ senior-level marketing professionals working in the pharmaceutical, biotechnology and medical device industries to learn, engage and network.
With 130+ senior-level experts speaking on the program and 60+ keynotes, case studies, panel discussions and education sessions spread over four days, this is the ideal forum to learn from and meet with industry veterans to understand current trends, innovation and effective…
8th Annual Clinical Quality Oversight Forum Early Bird Rates Expire Soon
Monday August 21st, 2017
ExL’s 8th Clinical Quality Oversight Forum focuses on ensuring trial integrity by effectively assessing, optimizing and managing the quality of clinical vendors and sites. Is your company represented at the only event on clinical quality oversight? Join 150+ of your colleagues on October 11–13 in Philadelphia and ensure the integrity of your clinical trial through effective oversight of your clinical vendors and sites. Register by THIS FRIDAY, August 25, for maximum savings with Early Bird rates.
This forum acts as the annual gathering for clinical quality, operations, management…
Just Announced: The 4th Rx-to-OTC Switch Summit!
Thursday August 17th, 2017
ExL Events is excited to present the 4th Rx-to-OTC Switch Summit, taking place on December 6–7, 2017 in Philadelphia. The Summit will bring together experts to provide a complete understanding of the switch landscape from quality, testing, regulatory strategy and marketing standpoints.
Now in its fourth consecutive year, ExL’s Rx-to-OTC Switch Summit is the most advanced thought leadership event that experts can attend to discuss all aspects of a switch from the NDA process to the…
Increasing Disease Awareness With Social Media
Tuesday August 15th, 2017
Regardless of your views on certain social media accounts and posts, there’s no denying the influence that Twitter, Facebook, and other platforms have on the public. So why not embrace these social networks to spread knowledge? Those in the life sciences understand the importance of disease awareness, so adding social media into the equation is a clear path for the industry.
Posts from professionals, patients, and more can sway the public’s knowledge about diseases and what those diseases entail. Also, just as social media has influenced opinions and changed minds, taboo ailments (i.e., mental illness, HIV,…
From The Blog
- Commercial Strategy
- Content Marketing
- Data Management
- Digital Marketing
- Drug Safety
- Emerging Markets
- ExL Events News
- Medical Devices
- Medical Education
- Meeting Planning
- Patient Engagement
- Public/Government Relations
- Regulatory Affairs